US EditionFujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection
- Fujitsu Limited and Acer Medical Inc. announced a partnership to develop 'aiGait' for assessing disease risk through gait pattern detection, as stated in their agreement signed on June 25, 2025.
- The initial testing will take place at the daycare center of Taipei Veterans Hospital, utilizing cameras to capture patient movements, according to the announcement.
- Acer Medical plans to introduce this solution to elderly care facilities across Taiwan by the end of 2025, leveraging Fujitsu's AI technology.
- The goal of this collaboration is to address social challenges related to gait abnormalities and early symptoms of dementia and Parkinson's disease, as outlined by both companies.
Insights by Ground AI
Does this summary seem wrong?
52 Articles
52 Articles
Rutland Herald+51 Reposted by 51 other sources
Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection
TOKYO, July 15, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to develop "aiGait" powered by Uvance, a solution that leverages Fujitsu's advanced skeleton recognition…
Coverage Details
Total News Sources52
Leaning Left8Leaning Right4Center19Last UpdatedBias Distribution61% Center
Bias Distribution
- 61% of the sources are Center
61% Center
L 26%
C 61%
13%
Factuality
To view factuality data please Upgrade to Premium
